Optimisation de l’interrogatoire dans l’évaluation du risque de maladie thromboembolique veineuse : l’étude OPTIMEV

Fowkes, 2003, Incidence of diagnosed deep vein thrombosis in the general population: systematic review, Eur J Vasc Endovasc Surg, 25, 1, 10.1053/ejvs.2002.1778 Coombes, 2005, Venous thromboembolism caused 25,000 deaths a year, say MPs, BMJ, 330, 559, 10.1136/bmj.330.7491.559-c Horlander, 2003, Pulmonary embolism mortality in the United States, 1979-1998: an analysis using multiple-cause mortality data, Arch Intern Med, 163, 1711, 10.1001/archinte.163.14.1711 Benard, 2005, Epidemiology of venous thromboembolic disease, Presse Med, 34, 415, 10.1016/S0755-4982(05)83934-X Prandoni, 2004, Below-knee elastic compression stockings to prevent the post-thrombotic syndrome: a randomized, controlled trial, Ann Intern Med, 141, 249, 10.7326/0003-4819-141-4-200408170-00004 Kearon, 2004, Long-term management of patients after venous thromboembolism, Circulation, 110, I10, 10.1161/01.CIR.0000140902.46296.ae Handley, 1972, Low-dose heparin after myocardial infarction, Lancet, 2, 623, 10.1016/S0140-6736(72)93016-4 Brach, 1977, Venous thrombosis in acute spinal cord paralysis, J Trauma, 17, 289, 10.1097/00005373-197704000-00005 McCarthy, 1977, Low-dose heparin as a prophylaxis against deep-vein thrombosis after acute stroke, Lancet, 2, 800, 10.1016/S0140-6736(77)90728-0 Geerts, 1994, A prospective study of venous thromboembolism after major trauma, N Engl J Med, 331, 1601, 10.1056/NEJM199412153312401 Anderson, 1992, The prevalence of risk factors for venous thromboembolism among hospital patients, Arch Intern Med, 152, 1660, 10.1001/archinte.1992.00400200092017 Warwick, 1995, Death and thromboembolic disease after total hip replacement. A series of 1162 cases with no routine chemical prophylaxis, J Bone Joint Surg Br, 77, 6, 10.1302/0301-620X.77B1.7822397 Goldhaber, 2004, A prospective registry of 5, 451 patients with ultrasound-confirmed deep vein thrombosis, Am J Cardiol, 93, 259, 10.1016/j.amjcard.2003.09.057 Kyrle, 2002, The risk of recurrent venous thromboembolism, Vasa, 31, 163, 10.1024/0301-1526.31.3.163 Dalen, 2002, Pulmonary embolism: what have we learned since Virchow? Natural history, pathophysiology, and diagnosis, Chest, 122, 1440, 10.1378/chest.122.4.1440 Dalen, 2002, Pulmonary embolism: what have we learned since Virchow? Treatment and prevention, Chest, 122, 1801, 10.1378/chest.122.5.1801 Anderson, 1991, A population-based perspective of the hospital incidence and case-fatality rates of deep vein thrombosis and pulmonary embolism. The Worcester DVT Study, Arch Intern Med, 151, 933, 10.1001/archinte.1991.00400050081016 Geerts, 2001, Prevention of venous thromboembolism, Chest, 119, 132S, 10.1378/chest.119.1_suppl.132S Ginsberg, 1995, Antiphospholipid antibodies and venous thromboembolism, Blood, 86, 3685, 10.1182/blood.V86.10.3685.bloodjournal86103685 Goldhaber, 2003, DVT Prevention: what is happening in the “ real world ” ?, Semin Thromb Hemost, 29, 23, 10.1055/s-2003-45414 Macdonald, 2003, Short-term natural history of isolated gastrocnemius and soleal vein thrombosis, J Vasc Surg, 37, 523, 10.1067/mva.2003.149 Wells, 1995, Accuracy of clinical assessment of deep-vein thrombosis, Lancet, 345, 1326, 10.1016/S0140-6736(95)92535-X Rodger, 2005, The interobserver reliability of pretest probability assessment in patients with suspected pulmonary embolism, Thromb Res, 116, 101, 10.1016/j.thromres.2004.10.011 Constans, 2003, Comparison of four clinical prediction scores for the diagnosis of lower limb deep venous thrombosis in outpatients, Am J Med, 115, 436, 10.1016/S0002-9343(03)00432-7 Prandoni, 2002, Residual venous thrombosis as a predictive factor of recurrent venous thromboembolism, Ann Intern Med, 137, 955, 10.7326/0003-4819-137-12-200212170-00008 Bonifacj, 1997, Case control studies of the risk factors for deep-vein thrombosis in an adult population hospitalized in internal medicine, Rev Epidemiol Sante Publique, 45, 465 Christiansen, 2005, Thrombophilia, clinical factors, and recurrent venous thrombotic events, JAMA, 293, 2352, 10.1001/jama.293.19.2352 Flordal, 1996, Risk factors for major thromboembolism and bleeding tendency after elective general surgical operations. The Fragmin Multicentre Study Group, Eur J Surg, 162, 783 Hansson, 2000, Recurrent venous thromboembolism after deep vein thrombosis: incidence and risk factors, Arch Intern Med, 160, 769, 10.1001/archinte.160.6.769 Heit, 2000, Risk factors for deep vein thrombosis and pulmonary embolism: a population-based case-control study, Arch Intern Med, 160, 809, 10.1001/archinte.160.6.809 Kyrle, 2003, The risk of recurrent venous thromboembolism: the Austrian study on recurrent venous thromboembolism, Wien Klin Wochenschr, 115, 471, 10.1007/BF03041030 Prandoni, 1998, Long-term outcomes after deep venous thrombosis of the lower extremities, Vasc Med, 3, 57, 10.1177/1358836X9800300112 Samama, 2000, An epidemiologic study of risk factors for deep vein thrombosis in medical outpatients: the Sirius study, Arch Intern Med, 160, 3415, 10.1001/archinte.160.22.3415 Schonauer, 2003, Superficial thrombophlebitis and risk for recurrent venous thromboembolism, J Vasc Surg, 37, 834, 10.1067/mva.2003.157 Laporte, 2003, The location of deep-vein thrombosis as a predictive factor for recurrence and cancer discovery after proximal deep-vein thrombosis, Haematologica, 88, ELT08 Douketis, 2001, Does the location of thrombosis determine the risk of disease recurrence in patients with proximal deep vein thrombosis?, Am J Med, 110, 515, 10.1016/S0002-9343(01)00661-1 Kyrle, 2004, The risk of recurrent venous thromboembolism in men and women, N Engl J Med, 350, 2558, 10.1056/NEJMoa032959 van Dongen, 2003, The incidence of recurrent venous thromboembolism after treatment with vitamin K antagonists in relation to time since first event: a meta-analysis, Arch Intern Med, 163, 1285, 10.1001/archinte.163.11.1285 Heit, 2000, Predictors of recurrence after deep vein thrombosis and pulmonary embolism: a population-based cohort study, Arch Intern Med, 160, 761, 10.1001/archinte.160.6.761 Eichinger, 2004, Symptomatic pulmonary embolism and the risk of recurrent venous thromboembolism, Arch Intern Med, 164, 92, 10.1001/archinte.164.1.92 Bura, 2004, Incidence and prognosis of cancer associated with bilateral venous thrombosis: a prospective study of 103 patients, J Thromb Haemost, 2, 441, 10.1111/j.1538-7933.2004.00619.x Seinturier, 2005, Site and clinical outcome of deep vein thrombosis of the lower limbs: an epidemiological study, J Thromb Haemost, 3, 1362, 10.1111/j.1538-7836.2005.01393.x Frezzato, 1996, Validated questionnaire for the identification of previous personal or familial venous thromboembolism, Am J Epidemiol, 143, 1257, 10.1093/oxfordjournals.aje.a008713 Bergqvist, 2004, Low molecular weight heparin for the prevention of venous thromboembolism after abdominal surgery, Br J Surg, 91, 965, 10.1002/bjs.4639 Barrellier, 1994, Echo-Doppler for early diagnosis of deep venous thrombosis in orthopedic surgery and traumatology. A retrospective study of 1,647 patients, J Mal Vasc, 19, 298 Flinn, 1996, Prospective surveillance for perioperative venous thrombosis. Experience in 2643 patients, Arch Surg, 131, 472, 10.1001/archsurg.1996.01430170018002 Tooher, 2005, A systematic review of strategies to improve prophylaxis for venous thromboembolism in hospitals, Ann Surg, 241, 397, 10.1097/01.sla.0000154120.96169.99 Geerts, 2004, Prevention of venous thromboembolism: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy, Chest, 126, 338S, 10.1378/chest.126.3_suppl.338S Powers, 1982, Prophylaxis of thromboembolism in the neurosurgical patient: a review, Neurosurgery, 10, 509, 10.1227/00006123-198204000-00018 Mismetti, 2001, Meta-analysis of low molecular weight heparin in the prevention of venous thromboembolism in general surgery, Br J Surg, 88, 913, 10.1046/j.0007-1323.2001.01800.x Lee, 2003, Epidemiology and management of venous thromboembolism in patients with cancer, Thromb Res, 110, 167, 10.1016/S0049-3848(03)00347-5 Sorensen, 1998, The risk of a diagnosis of cancer after primary deep venous thrombosis or pulmonary embolism, N Engl J Med, 338, 1169, 10.1056/NEJM199804233381701 Sorensen, 2000, Prognosis of cancers associated with venous thromboembolism, N Engl J Med, 343, 1846, 10.1056/NEJM200012213432504 Cogo, 1994, Acquired risk factors for deep-vein thrombosis in symptomatic outpatients, Arch Intern Med, 154, 164, 10.1001/archinte.1994.00420020066008 Tsai, 2002, Cardiovascular risk factors and venous thromboembolism incidence: the longitudinal investigation of thromboembolism etiology, Arch Intern Med, 162, 1182, 10.1001/archinte.162.10.1182 Verso, 2003, Venous thromboembolism associated with long-term use of central venous catheters in cancer patients, J Clin Oncol, 21, 3665, 10.1200/JCO.2003.08.008 Thodiyil, 2002, Variation in relative risk of venous thromboembolism in different cancers, Thromb Haemost, 87, 1076, 10.1055/s-0037-1613136 Gatt, 2004, Is prolonged immobilization a risk factor for symptomatic venous thromboembolism in elderly bedridden patients? Results of a historical-cohort study, Thromb Haemost, 91, 538, 10.1160/TH03-07-0481 Heit, 2001, Incidence of venous thromboembolism in hospitalized patients vs community residents, Mayo Clin Proc, 76, 1102, 10.4065/76.11.1102 Mismetti, 2002, Thromboprophylaxis in acute medical patients: need for an implementation strategy, Haematologica, 87, 673 Mismetti, 2000, Prevention of venous thromboembolism in internal medicine with unfractionated or low-molecular-weight heparins: a meta-analysis of randomised clinical trials, Thromb Haemost, 83, 14, 10.1055/s-0037-1613749 Samama, 1999, A comparison of enoxaparin with placebo for the prevention of venous thromboembolism in acutely ill medical patients. Prophylaxis in Medical Patients with Enoxaparin Study Group, N Engl J Med, 341, 793, 10.1056/NEJM199909093411103 Heit, 2002, Relative impact of risk factors for deep vein thrombosis and pulmonary embolism: a population-based study, Arch Intern Med, 162, 1245, 10.1001/archinte.162.11.1245 Bosson, 2003, Deep vein thrombosis in elderly patients hospitalized in subacute care facilities: a multicenter cross-sectional study of risk factors, prophylaxis, and prevalence, Arch Intern Med, 163, 2613, 10.1001/archinte.163.21.2613 Samama, 2003, Quantification of risk factors for venous thromboembolism: a preliminary study for the development of a risk assessment tool, Haematologica, 88, 1410 Oger, 1997, The value of a risk factor analysis in clinically suspected deep venous thrombosis, Respiration, 64, 326, 10.1159/000196699 Weill-Engerer, 2004, Risk factors for deep vein thrombosis in inpatients aged 65 and older: a case-control multicenter study, J Am Geriatr Soc, 52, 1299, 10.1111/j.1532-5415.2004.52359.x Kyrle, 2005, Deep vein thrombosis, Lancet, 365, 1163, 10.1016/S0140-6736(05)71880-8 van der Meer, 1997, The Leiden Thrombophilia Study (LETS), Thromb Haemost, 78, 631, 10.1055/s-0038-1657602 Rosendaal, 1999, Venous thrombosis: a multicausal disease, Lancet, 353, 1167, 10.1016/S0140-6736(98)10266-0 Quere, 2002, Red blood cell methylfolate and plasma homocysteine as risk factors for venous thromboembolism: a matched case-control study, Lancet, 359, 747, 10.1016/S0140-6736(02)07876-5 Kemmeren, 2001, Third generation oral contraceptives and risk of venous thrombosis: meta-analysis, BMJ, 323, 131, 10.1136/bmj.323.7305.131 Ray, 2001, Use of statins and the subsequent development of deep vein thrombosis, Arch Intern Med, 161, 1405, 10.1001/archinte.161.11.1405 Ridker, 2003, Long-term, low-intensity warfarin therapy for the prevention of recurrent venous thromboembolism, N Engl J Med, 348, 1425, 10.1056/NEJMoa035029 Zornberg, 2000, Antipsychotic drug use and risk of first-time idiopathic venous thromboembolism: a case-control study, Lancet, 356, 1219, 10.1016/S0140-6736(00)02784-7 Prevention of pulmonary embolism and deep vein thrombosis with low dose aspirin: Pulmonary Embolism Prevention (PEP) trial. Lancet, 2000 ; 355 : 1295-302. Decousus, 1998, A clinical trial of vena caval filters in the prevention of pulmonary embolism in patients with proximal deep-vein thrombosis. Prévention du Risque d’Embolie Pulmonaire par Interruption Cave Study Group, N Engl J Med, 338, 409, 10.1056/NEJM199802123380701 Gruel, 2004, Heparin-induced thrombocytopenia. Pathogenesis, diagnosis and treatment, Rev Med Interne, 25, 35, 10.1016/S0248-8663(03)00109-7 Hagg, 2002, Antipsychotic-induced venous thromboembolism: a review of the evidence, CNS Drugs, 16, 765, 10.2165/00023210-200216110-00005 Kearon, 2003, Comparison of low-intensity warfarin therapy with conventional-intensity warfarin therapy for long-term prevention of recurrent venous thromboembolism, N Engl J Med, 349, 631, 10.1056/NEJMoa035422 Yang, 2002, Statins and the risk of idiopathic venous thromboembolism, Br J Clin Pharmacol, 53, 101, 10.1046/j.0306-5251.2001.01523.x Kurz, 1999, Chronic venous disorders of the leg: epidemiology, outcomes, diagnosis and management. Summary of an evidence-based report of the VEINES task force. Venous Insufficiency Epidemiologic and Economic Studies, Int Angiol, 18, 83 Goldhaber, 2003, Acute pulmonary embolism: part II: risk stratification, treatment, and prevention, Circulation, 108, 2834, 10.1161/01.CIR.0000098427.74047.42 Goldhaber, 2003, Acute pulmonary embolism: part I: epidemiology, pathophysiology, and diagnosis, Circulation, 108, 2726, 10.1161/01.CIR.0000097829.89204.0C